138 related articles for article (PubMed ID: 32590239)
1. Chemokine gene expression influences metastasis and survival time of female dogs with mammary carcinoma.
Ariyarathna H; Thomson N; Aberdein D; Munday JS
Vet Immunol Immunopathol; 2020 Sep; 227():110075. PubMed ID: 32590239
[TBL] [Abstract][Full Text] [Related]
2. Increased programmed death ligand (PD-L1) and cytotoxic T-lymphocyte antigen-4 (CTLA-4) expression is associated with metastasis and poor prognosis in malignant canine mammary gland tumours.
Ariyarathna H; Thomson NA; Aberdein D; Perrott MR; Munday JS
Vet Immunol Immunopathol; 2020 Dec; 230():110142. PubMed ID: 33129194
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of chemokines CCL2 and CXCL12 in female dogs with malignant mammary gland tumours without and with metastases.
Szczubiał M; Łopuszyński W; Dąbrowski R; Jamioł M; Bochniarz M; Brodzki P
Pol J Vet Sci; 2023 Sep; 26(3):385-392. PubMed ID: 37727066
[TBL] [Abstract][Full Text] [Related]
4. The Expression of Selected Factors Related to T Lymphocyte Activity in Canine Mammary Tumors.
Bujak JK; Szopa IM; Pingwara R; Kruczyk O; Krzemińska N; Mucha J; Majchrzak-Kuligowska K
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225066
[TBL] [Abstract][Full Text] [Related]
5. Chemokine and chemokine receptor patterns in patients with benign and malignant salivary gland tumors: a distinct role for CCR7.
Haghshenas MR; Ashraf MJ; Khademi B; Ghaderi A; Erfani N; Razmkhah M
Eur Cytokine Netw; 2017 Mar; 28(1):27-35. PubMed ID: 28840842
[TBL] [Abstract][Full Text] [Related]
6. Low Stromal Mast Cell Density in Canine Mammary Gland Tumours Predicts a Poor Prognosis.
Ariyarathna H; Thomson N; Aberdein D; Munday JS
J Comp Pathol; 2020 Feb; 175():29-38. PubMed ID: 32138840
[TBL] [Abstract][Full Text] [Related]
7. Naturally Leishmania infantum-infected dogs display an overall impairment of chemokine and chemokine receptor expression during visceral leishmaniasis.
Nascimento MS; Albuquerque TD; Do-Valle-Matta MA; Caldas IS; Diniz LF; Talvani A; Bahia MT; Andrade CM; Galvão LM; Câmara AC; Guedes PM
Vet Immunol Immunopathol; 2013 Jun; 153(3-4):202-8. PubMed ID: 23545087
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein expression in canine malignant mammary tumours.
Romanucci M; Marinelli A; Sarli G; Della Salda L
BMC Cancer; 2006 Jun; 6():171. PubMed ID: 16803633
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.
Bulkowska M; Rybicka A; Senses KM; Ulewicz K; Witt K; Szymanska J; Taciak B; Klopfleisch R; Hellmén E; Dolka I; Gure AO; Mucha J; Mikow M; Gizinski S; Krol M
BMC Cancer; 2017 Nov; 17(1):728. PubMed ID: 29115935
[TBL] [Abstract][Full Text] [Related]
12. Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells.
Sucur A; Jajic Z; Artukovic M; Matijasevic MI; Anic B; Flegar D; Markotic A; Kelava T; Ivcevic S; Kovacic N; Katavic V; Grcevic D
Arthritis Res Ther; 2017 Jun; 19(1):142. PubMed ID: 28619088
[TBL] [Abstract][Full Text] [Related]
13. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
[TBL] [Abstract][Full Text] [Related]
14. Expression of chemokines and chemokine receptors in brain tumor tissue derived cells.
Razmkhah M; Arabpour F; Taghipour M; Mehrafshan A; Chenari N; Ghaderi A
Asian Pac J Cancer Prev; 2014; 15(17):7201-5. PubMed ID: 25227814
[TBL] [Abstract][Full Text] [Related]
15. Solitary and multiple simultaneous malignant epithelial mammary tumours in dogs: An explorative retrospective study.
Pecile A; Groppetti D; Ferrari R; Grieco V; Giudice C; Spediacci C; Stefanello D; Boracchi P
Res Vet Sci; 2021 Mar; 135():153-161. PubMed ID: 33524825
[TBL] [Abstract][Full Text] [Related]
16. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
Morein D; Erlichman N; Ben-Baruch A
Front Immunol; 2020; 11():952. PubMed ID: 32582148
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
[TBL] [Abstract][Full Text] [Related]
18. Expression and activation of platelet-derived growth factor β receptor, mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) and extracellular signal-regulated kinase (ERK) in canine mammary tumours.
Altamura G; Uberti BD; Galiero G; Martano M; Pirro A; Russo M; Borzacchiello G
Res Vet Sci; 2017 Feb; 110():29-33. PubMed ID: 28159233
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of FOXP3 expression in canine mammary gland tumours.
Oh SY; Ryu HH; Yoo DY; Hwang IK; Kweon OK; Kim WH
Vet Comp Oncol; 2014 Mar; 12(1):20-8. PubMed ID: 22541038
[TBL] [Abstract][Full Text] [Related]
20. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
